Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Bob Rhatigan
|
| gptkbp:focus |
injectables
cosmetic dermatology minimally invasive aesthetics |
| gptkbp:foundedBy |
gptkb:Friedrich_Merz
|
| gptkbp:foundedYear |
1908
|
| gptkbp:headquartersLocation |
gptkb:Frankfurt,_Germany
|
| gptkbp:industry |
aesthetics
pharmaceuticals medical devices |
| gptkbp:operatesIn |
global
|
| gptkbp:parentCompany |
gptkb:Merz_Pharma
|
| gptkbp:products |
gptkb:Radiesse
gptkb:Xeomin gptkb:Belotero Ultherapy |
| gptkbp:subsidiary |
Merz Group
|
| gptkbp:type |
private
|
| gptkbp:website |
https://www.merzaesthetics.com/
|
| gptkbp:bfsParent |
gptkb:Merz_Pharma
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merz Aesthetics
|